Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Drinks Industry News Food Industry News Is postbiotic fortification the next big thing in gut health for food brands testing innovations in 2025? Explore how postbiotic fortification is reshaping shelf-stable gut-health foods in 2025. Learn market size, regulation, innovation, and future outlook. byPallavi MadhirajuJune 27, 2025